G1 Therapeutics (GTHX) PT Lowered to $33 at Roth Capital
Tweet
Share
E-mailGet Alerts GTHX Hot Sheet
Price: $7.15 --0%
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Roth Capital analyst Tony Butler lowered the price target on G1 Therapeutics (NASDAQ: GTHX) to $33.00 (from $35.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Downgrades Inpex Corp (1605:JP) to Neutral
- Climb Bio (CLYM) PT Raised to $25 at Baird
- Oracle Corp Japan (4716:JP) (OCLCF) PT Lowered to JPY13,000 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
